Relapsed Diffuse Large B-Cell Lymphoma: Clinical Utility of Cell of Origin

被引：5
|
作者：
Vose, Julie M. [1 ]
机构：
[1] Univ Nebraska Med Ctr, Omaha, NE 68198 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 31期
关键词：
TISSUE MICROARRAY; GERMINAL CENTER; SURVIVAL; IMMUNOHISTOCHEMISTRY; CHEMOTHERAPY; RITUXIMAB; SUBTYPES; IMPROVES;
D O I：
10.1200/JCO.2011.37.5733
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4065 / 4066
页数：2
相关论文
共 50 条
  • [21] Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Schuster, Stephen J.
    Bishop, Michael R.
    Tam, Constantine S.
    Waller, Edmund K.
    Borchmann, Peter
    McGuirk, Joseph P.
    Jaeger, Ulrich
    Jaglowski, Samantha
    Andreadis, Charalambos
    Westin, Jason R.
    Fleury, Isabelle
    Bachanova, Veronika
    Foley, S. Ronan
    Ho, P. Joy p
    Mielke, Stephan
    Magenau, John M.
    Holte, Harald
    Pantano, Serafino
    Pacaud, Lida B.
    Awasthi, Rakesh
    Chu, Jufen
    Anak, Ozlem
    Salles, Gilles
    Maziarz, Richard T.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (01) : 45 - 56
  • [22] The efficacy and safety of autologous stem cell transplantation in relapsed chemosensitive and chemoresistant patients with diffuse large B-cell lymphoma
    Armatys, A.
    Wieczorkiewicz-Kabut, A.
    Panz-Klapuch, M.
    Koclega, A.
    Kopinska, A. J.
    Kata, D.
    Wozniczka, K.
    Helbig, G.
    NEOPLASMA, 2020, 67 (06) : 1431 - 1436
  • [23] Differential Therapy for Diffuse Large B-Cell Lymphoma with Different Cells of Origin
    Murawski, Niels
    Pfreundschuh, Michael
    ONKOLOGIE, 2009, 32 (12): : 711 - 712
  • [24] Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Is It a Valid Treatment Option?
    Mondello, Patrizia
    Steiner, Normann
    Willenbacher, Wolfgang
    Ferrero, Simone
    Ghione, Paola
    Marabese, Alessandra
    Pitini, Vincenzo
    Cuzzocrea, Salvatore
    Mian, Michael
    ONCOLOGIST, 2016, 21 (09) : 1107 - 1112
  • [25] A prognostic nomogram constructed for relapsed or refractory diffuse large B-cell lymphoma patients
    Jiang, Shiyu
    Qin, Yan
    Liu, Peng
    Yang, Jianliang
    Yang, Sheng
    He, Xiaohui
    Zhou, Shengyu
    Gui, Lin
    Zhang, Changgong
    Zhou, Liqiang
    Sun, Yan
    Shi, Yuankai
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 (02) : E11 - E16
  • [26] Diffuse Large B-Cell Lymphoma
    Friedberg, Jonathan W.
    Fisher, Richard I.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2008, 22 (05) : 941 - +
  • [27] Diffuse large B-cell lymphoma
    Li, Shaoying
    Young, Ken H.
    Medeiros, L. Jeffrey
    PATHOLOGY, 2018, 50 (01) : 74 - 87
  • [28] Diffuse large B-cell lymphoma
    Fuchs, David
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2019, 12 (01) : 7 - 11
  • [29] New and emerging therapies for the treatment of relapsed/refractory diffuse large B-cell lymphoma
    Moore, Donald C.
    Peery, Matthew R.
    Tobon, Katherine A.
    Raheem, Farah
    Hwang, Grace S.
    Alhennawi, Lin
    Hughes, Mitchell E.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (08) : 1848 - 1858
  • [30] Diffuse large B-cell lymphoma
    Martelli, Maurizio
    Ferreri, Andres J. M.
    Agostinelli, Claudio
    Di Rocco, Alice
    Pfreundschuh, Michael
    Pileri, Stefano A.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 87 (02) : 146 - 171
12345